Weight Loss
Survodutide
Research use only. This protocol is compiled from published research literature and community documentation. It is for educational reference only and does not constitute medical advice.
Start Dose
0.6mg weekly SubQ
Begin here. Titrate conservatively based on response.
Standard Range
0.6mg → 6mg weekly. Titration: Weeks 1-4: 0.6mg. Weeks 5-8: 1.2mg. Weeks 9-12: 2.4mg. Weeks 13-16: 3.6mg. Weeks 17-20: 4.8mg. Weeks 21+: 6mg.
Titration Path
Follow 4-week titration steps. Max 6mg weekly.
Cycle
0
Weeks On
0
Weeks Off
Continuous use acceptable.
Routes
subcutaneous
Titration schedule: Weeks 1-4: 0.6mg. Weeks 5-8: 1.2mg. Weeks 9-12: 2.4mg. Weeks 13-16: 3.6mg. Weeks 17-20: 4.8mg. Weeks 21+: 6mg.
Notes
Dual GLP-1/glucagon receptor agonist. Weight management, NASH/MASH research.